293 related articles for article (PubMed ID: 32112296)
1. Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.
Beccaria K; Sabbagh A; de Groot J; Canney M; Carpentier A; Heimberger AB
J Neurooncol; 2021 Jan; 151(1):65-73. PubMed ID: 32112296
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors.
Beccaria K; Canney M; Bouchoux G; Desseaux C; Grill J; Heimberger AB; Carpentier A
Cancer Lett; 2020 Jun; 479():13-22. PubMed ID: 32112904
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery.
Arsiwala TA; Sprowls SA; Blethen KE; Adkins CE; Saralkar PA; Fladeland RA; Pentz W; Gabriele A; Kielkowski B; Mehta RI; Wang P; Carpenter JS; Ranjan M; Najib U; Rezai AR; Lockman PR
Neoplasia; 2021 Jul; 23(7):676-691. PubMed ID: 34139452
[TBL] [Abstract][Full Text] [Related]
5. Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.
Chen PY; Hsieh HY; Huang CY; Lin CY; Wei KC; Liu HL
J Transl Med; 2015; 13():93. PubMed ID: 25784614
[TBL] [Abstract][Full Text] [Related]
6. Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
Sabbagh A; Beccaria K; Ling X; Marisetty A; Ott M; Caruso H; Barton E; Kong LY; Fang D; Latha K; Zhang DY; Wei J; DeGroot J; Curran MA; Rao G; Hu J; Desseaux C; Bouchoux G; Canney M; Carpentier A; Heimberger AB
Clin Cancer Res; 2021 Aug; 27(15):4325-4337. PubMed ID: 34031054
[TBL] [Abstract][Full Text] [Related]
7. Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery.
Lin CY; Hsieh HY; Pitt WG; Huang CY; Tseng IC; Yeh CK; Wei KC; Liu HL
J Control Release; 2015 Aug; 212():1-9. PubMed ID: 26071631
[TBL] [Abstract][Full Text] [Related]
8. Effects of Low-Intensity Pulsed Ultrasound-Induced Blood-Brain Barrier Opening in P301S Mice Modeling Alzheimer's Disease Tauopathies.
Géraudie A; Riche M; Lestra T; Trotier A; Dupuis L; Mathon B; Carpentier A; Delatour B
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569786
[TBL] [Abstract][Full Text] [Related]
9. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.
Shin J; Kong C; Cho JS; Lee J; Koh CS; Yoon MS; Na YC; Chang WS; Chang JW
Neurosurg Focus; 2018 Feb; 44(2):E15. PubMed ID: 29385915
[TBL] [Abstract][Full Text] [Related]
10. Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model.
Yang FY; Lin GL; Horng SC; Chang TK; Wu SY; Wong TT; Wang HE
IEEE Trans Ultrason Ferroelectr Freq Control; 2011 May; 58(5):964-70. PubMed ID: 21622052
[TBL] [Abstract][Full Text] [Related]
11. Application of low-intensity ultrasound by opening blood-brain barrier for enhanced brain-targeted drug delivery.
Li Q; Tang Z; Zhang Y; Yuan T; Yuan B; Du L; Jin Y
Int J Pharm; 2023 Jul; 642():123191. PubMed ID: 37391108
[TBL] [Abstract][Full Text] [Related]
12. Neural immune modulation and immunotherapy assisted by focused ultrasound induced blood-brain barrier opening.
Chen PY; Wei KC; Liu HL
Hum Vaccin Immunother; 2015; 11(11):2682-7. PubMed ID: 26378609
[TBL] [Abstract][Full Text] [Related]
13. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
14. MR-guided focused ultrasound-induced blood-brain barrier opening for brain metastasis: a review.
Grasso G; Torregrossa F; Noto M; Bruno E; Feraco P; Buscemi F; Bartolotta TV; Gagliardo C
Neurosurg Focus; 2023 Aug; 55(2):E11. PubMed ID: 37527681
[TBL] [Abstract][Full Text] [Related]
15. BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains.
Cooper I; Last D; Ravid O; Rand D; Matsree E; Omesi L; Shemesh C; Liberman M; Zach L; Furman O; Daniels D; Liraz-Zaltsman S; Mardor Y; Sharabi S
Fluids Barriers CNS; 2023 Sep; 20(1):67. PubMed ID: 37737197
[TBL] [Abstract][Full Text] [Related]
16. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
Horodyckid C; Canney M; Vignot A; Boisgard R; Drier A; Huberfeld G; François C; Prigent A; Santin MD; Adam C; Willer JC; Lafon C; Chapelon JY; Carpentier A
J Neurosurg; 2017 Apr; 126(4):1351-1361. PubMed ID: 27285538
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of blood-brain barrier disruption by pulsed ultrasound.
Carpentier A; Canney M; Vignot A; Reina V; Beccaria K; Horodyckid C; Karachi C; Leclercq D; Lafon C; Chapelon JY; Capelle L; Cornu P; Sanson M; Hoang-Xuan K; Delattre JY; Idbaih A
Sci Transl Med; 2016 Jun; 8(343):343re2. PubMed ID: 27306666
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
Rezai AR; Ranjan M; D'Haese PF; Haut MW; Carpenter J; Najib U; Mehta RI; Chazen JL; Zibly Z; Yates JR; Hodder SL; Kaplitt M
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9180-9182. PubMed ID: 32284421
[TBL] [Abstract][Full Text] [Related]
19. Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model.
Ahmed MH; Hernández-Verdin I; Quissac E; Lemaire N; Guerin C; Guyonnet L; Zahr N; Mouton L; Santin M; Petiet A; Schmitt C; Bouchoux G; Canney M; Sanson M; Verreault M; Carpentier A; Idbaih A
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839777
[TBL] [Abstract][Full Text] [Related]
20. Low intensity focused ultrasound: a new prospect for the treatment of Parkinson's disease.
Zhong YX; Liao JC; Liu X; Tian H; Deng LR; Long L
Ann Med; 2023; 55(2):2251145. PubMed ID: 37634059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
